Medicated Skin Care in the US

Date: April 3, 2012
Pages: 53
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M2E70A2156BEN
Leaflet:

Download PDF Leaflet

Medicated skin care continued to benefit from growing consumer demand in a variety of specialty/niche segments. Hair loss treatments, for example, continued to benefit from an ageing population in the US and witnessed current value retail growth of 4% in 2011. Nappy (diaper) rash treatments also continued to grow – leaping 7% in current value terms in 2011 – as budget-minded parents overextend the time their children are spending in their diapers, which increases the incidence of diaper rash.

Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Bayer Corp in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 1 Bayer Corp: Key Facts
Company Background
Production
Competitive Positioning
  Summary 2 Bayer Corp: Competitive Position 2011
Chattem Inc in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 3 Chattem Inc: Key Facts
Company Background
Production
Competitive Positioning
  Summary 4 Chattem Inc: Competitive Position 2011
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 5 CVS Caremark Corp: Key Facts
  Summary 6 CVS Caremark Corp: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 CVS Caremark Corp: Competitive Position 2011
GlaxoSmithKline Consumer Health in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 8 GlaxoSmithKline Consumer Health: Key Facts
Company Background
Production
Competitive Positioning
  Summary 9 GlaxoSmithKline Consumer Health: Competitive Position 2011
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 10 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
  Summary 11 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 12 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2011
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 13 Pfizer Consumer Healthcare Inc: Key Facts
Company Background
Production
Competitive Positioning
  Summary 14 Pfizer Consumer Healthcare Inc: Competitive Position 2011
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
  Summary 15 Walgreen Co: Key Facts
  Summary 16 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 17 Walgreen Co: Competitive Position 2011
Executive Summary
Consumer Health Sales Hit All-time High
Vitamins and Dietary Supplements Performs the Best
No End in Sight for Recalls
Distribution Continues To Consolidate
Growth Expected To Slow As Categories Mature, Sluggish Economy Persists
Key Trends and Developments
Persistent Recalls Define Another Year in OTC
Acquisitions Shake Up OTC Competitive Landscape
Increasing Media Attention Drives Supplementation Fever
Growing Mainstream Appeal Catapults Sports Nutrition Sales
Tonics and Bottled Nutritive Drinks: the New Mega-category
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 18 OTC - Switches 2009-2011
Sources
  Summary 19 Research Sources
Skip to top


Medicated Skin Care in Portugal US$ 990.00 Sep, 2012 · 26 pages
Medicated Skin Care - Singapore US$ 990.00 Mar, 2010 · 38 pages
Medicated Skin Care in Slovakia US$ 990.00 May, 2012 · 27 pages
Medicated Skin Care in Slovenia US$ 990.00 Oct, 2012 · 32 pages

Ask Your Question

Medicated Skin Care in the US
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: